Markets:

Overview

News

Currencies

International

Treasuries

Altimmune, Inc. - Common Stock (NQ:ALT)

3.100 +0.220 (+7.64%)

Streaming Delayed Price Updated: 1:22 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Altimmune, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Altimmune Inc. (NASDAQ: ALT) is One of Thursday Morning’s Most Active Stocks

December 07, 2023

Via Investor Brand Network

Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday ↗

December 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

Altimmune Inc. (NASDAQ: ALT) is One of Friday Morning’s Most Active Stocks

December 01, 2023

Via Investor Brand Network

Altimmune's Earnings Outlook ↗

November 06, 2023

Via Benzinga

Preview: Altimmune's Earnings ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 06, 2023

Via Benzinga

JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities ↗

December 06, 2023

Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer

Via Benzinga

PRISM MarketView Highlights Altimmune’s Positive Topline Results in Obesity Drug Trial

December 05, 2023

Via AB Newswire

While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer ↗

December 05, 2023

Obesity has been linked to development of a range of diseases and unfortunately, cancer. More specifically, the National Cancer Institute estimated that colorectal cancer is 1.3 times more likely in...

Via Benzinga

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs ↗

December 05, 2023

As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market ↗

December 04, 2023

Weight-loss drugs such as Ozempic and Mounjaro are the leading blockbusters for a new epidemic

Via Benzinga

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 01, 2023

Via Benzinga

Why Is Hub Cyber Security (HUBC) Stock Up 30% Today? ↗

December 01, 2023

Hub Cyber Security stock is rising higher on Friday as HUBC investors react to an expanded partnership with Blackswan Technologies.

Via InvestorPlace

Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 01, 2023

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.

Via Benzinga

Why Is Altimmune (ALT) Stock Up 43% Today? ↗

December 01, 2023

Altimmune stock is rising higher on Friday with heavy trading of ALT shares after posting positive results form a clinical trial.

Via InvestorPlace

Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review ↗

December 01, 2023

Software earnings were strong, while the Fed is shifting toward rate cuts.

Via Investor's Business Daily

Topics Economy Stocks

Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower ↗

December 01, 2023

Altimmune Inc (NASDAQ: ALT) announced topline results from its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 01, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 01, 2023

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 30, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 21, 2023

On Friday, 54 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.

Via Benzinga

5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies ↗

June 20, 2023

Via Benzinga

Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It ↗

June 14, 2023

Once a lesser-known health condition, now a problem crippling millions of people around the world: metabolic syndrome is unfortunately on the rise.

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.